• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION WOLVERINE CORONARY CUTTING BALLOON; CATHETER, PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA), CUTTING/SCORING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION WOLVERINE CORONARY CUTTING BALLOON; CATHETER, PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA), CUTTING/SCORING Back to Search Results
Model Number 3854
Device Problem Material Integrity Problem (2978)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 04/24/2019
Event Type  malfunction  
Event Description
It was reported that a device was not able to be visualized under fluoroscopy.A percutaneous coronary intervention was being performed.The 10mm x 3.0mm wolverine coronary cutting balloon was placed inside the patient's body.Once inflated, the physician was unable to see the balloon under fluoroscopy.The device was removed from the patient to be tested.The balloon inflated appropriately and the indeflator was checked for proper contrast.Once outside the patient, the balloon was again put under fluoroscopy and it was still not able to be visualized.The physician used another wolverine to complete the procedure.
 
Event Description
It was reported that a device was not able to be visualized under fluoroscopy.A percutaneous coronary intervention was being performed.The 10mm x 3.0mm wolverine coronary cutting balloon was placed inside the patient's body.Once inflated, the physician was unable to see the balloon under fluoroscopy.The device was removed from the patient to be tested.The balloon inflated appropriately and the indeflator was checked for proper contrast.Once outside the patient, the balloon was again put under fluoroscopy and it was still not able to be visualized.The physician used another wolverine to complete the procedure.
 
Manufacturer Narrative
Device returned to manufacturer: the wolverine coronary cutting balloon was returned and analysis was completed.A visual examination identified that the balloon was not folded which indicates that the balloon was subjected to positive pressure.The balloon was attached to a boston scientific encore inflation unit and positive pressure was applied and the balloon was inflated to its rated burst pressure using a solution of omnipaque and sodium chloride (nacl), mixed in 50:50 ratio.The inflation device was verified at 12atm (atmospheres), before and after use.The inflated device was placed under a c-arm fluoroscope and x-ray images were taken of the balloon section of the device.Fluoroscopy images clearly showed the balloon profile and markerbands of the returned device.No issues were noted with the tip section of the device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
WOLVERINE CORONARY CUTTING BALLOON
Type of Device
CATHETER, PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA), CUTTING/SCORING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key8619860
MDR Text Key145385232
Report Number2134265-2019-05057
Device Sequence Number1
Product Code NWX
UDI-Device Identifier08714729888260
UDI-Public08714729888260
Combination Product (y/n)N
PMA/PMN Number
P950020
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 07/02/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/13/2021
Device Model Number3854
Device Catalogue Number3854
Device Lot Number0023489138
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/13/2019
Initial Date Manufacturer Received 04/25/2019
Initial Date FDA Received05/17/2019
Supplement Dates Manufacturer Received06/11/2019
Supplement Dates FDA Received07/02/2019
Patient Sequence Number1
-
-